Diuretic-induced CNS magnesium alteration and digoxin intoxication

Area of Science:

• Pharmacology
• Neuroscience
• Toxicology

Background:

• Thiazide diuretics are commonly prescribed medications.
• Digoxin is a cardiac glycoside used to treat heart failure and arrhythmias.
• The central nervous system (CNS) role in drug toxicity is an area of ongoing research.

Purpose of the Study:

• To investigate the effect of thiazide diuretics on central nervous system magnesium levels.
• To determine if thiazide-induced magnesium depletion influences digoxin toxicity.
• To explore the potential therapeutic role of magnesium in mitigating digoxin intoxication.

Main Methods:

• Male Wistar rats were administered various thiazide diuretics intraperitoneally.
• Magnesium content was measured in different brain regions (hypothalamus, medulla oblongata, cerebral cortex) and peripheral tissues (heart, skeletal muscle, serum).
• Digoxin was infused in rats pretreated with hydrochlorothiazide to assess cardiac arrhythmias and the effect of central nervous system magnesium administration.

Main Results:

• Hydrochlorothiazide, chlorothiazide, and bendroflumethiazide significantly decreased magnesium levels in the hypothalamus and medulla oblongata.
• Metolazone increased magnesium levels in the hypothalamus and medulla oblongata.
• Pretreatment with hydrochlorothiazide accelerated the onset of digoxin-induced arrhythmias, which were partially reversed by central nervous system magnesium administration.

Conclusions:

• Thiazide diuretics, particularly hydrochlorothiazide, chlorothiazide, and bendroflumethiazide, induce magnesium depletion in the central nervous system.
• This CNS magnesium depletion is strongly implicated in predisposing animals to digoxin intoxication.
• Central nervous system magnesium plays a critical role in modulating the toxicity of cardiac glycosides like digoxin.